Skip to main content

Table 2 Epidemiological and anamnestic data of our COVID-19 patients

From: Gene signature and immune cell profiling by high-dimensional, single-cell analysis in COVID-19 patients, presenting Low T3 syndrome and coexistent hematological malignancies

Characteristics

All patients (n = 62)

Group A (n = 38)

Group B (n = 24)

P value

Age, years

68.4 (29–100)

70.5 (32–100)

65.5 (29–87)

NS

Sex

 Men

29 (47%)

19 (50%)

10 (42%)

NS

 Women

33 (53%)

19 (50%)

14 (58%)

NS

Current smoking

22 (35.5%)

10 (26.3%)

12 (50%)

0.03

Comorbidity (at least one)

54 (87.1%)

33 (86.8%)

21 (87.5%)

NS

 Diabetes

32 (51.6%)

24 (63.2%)

8 (33.3%)

0.03

 Hypertension

40 (64.5%)

18 (47.4%)

12 (50.0%)

NS

 Cardiovascular disease

27 (43.5%)

19 (50.0%)

8 (33.3%)

NS

 Chronic obstructive pulmonary disease

21 (33.9%)

11 (28.9%)

10 (41.7%)

NS

 Malignancy

9 (14.5%)

6 (15.8%)

3 (12.5%)

NS

 Multiple sclerosis

1 (1.6%)

0 (0%)

1 (4.2%)

NS

  1. Data are reported for all patients and for patients with low FT3 values (Group A), compared to those with normal FT3 values (Group B). The p values are indicated as a measure of the levels of significance of the differences among the two groups